Recap: NovaBay Pharmaceuticals Q2 Earnings

 

NovaBay Pharmaceuticals NBY reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

NovaBay Pharmaceuticals missed estimated earnings by 33.33%, reporting an EPS of $-0.04 versus an estimate of $-0.03.

Revenue was up $912 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 5.21% increase in the share price the next day.

 

To track all earnings releases for NovaBay Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

NBY Logo
NBYNovaBay Pharmaceuticals Inc
$0.5500-3.00%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
7.28
Growth
Not Available
Quality
Not Available
Value
94.71
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...